• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基底细胞癌X线治疗后的皮肤反应与生活质量

Skin reactions and quality of life after x-ray therapy of Basal cell carcinoma.

作者信息

Skiveren Jette, Mikkelsen Maria Rudkjaer, Daugbjerg Helle, Wulf Hans Christian

机构信息

Department of Dermatology, Copenhagen University Hospital, Bispebjerg Hospital, Copenhagen 2400, Denmark.

出版信息

J Skin Cancer. 2012;2012:825095. doi: 10.1155/2012/825095. Epub 2012 Dec 20.

DOI:10.1155/2012/825095
PMID:23316369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539380/
Abstract

Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray therapy compared with matched healthy controls. Materials. Twenty-five patients (mean age 69) with BCC completed the Dermatology Life Quality Index (DLQI) before and two weeks and three months after X-ray therapy and their results were compared with the DLQI scores for 25 matched controls. Results. Compared to the healthy controls the patients' DLQI score was significantly higher before and 2 weeks after X-ray therapy (P = 0.005; P = 0.000). The patients' DLQI score decreased significantly from baseline to three months after X-ray therapy (P = 0.024), when it became similar to that of the healthy controls (P = 0.819). Three months after X-ray therapy eight patients had no skin reactions, 11 had slight atrophy, pigmentation change, and/or some hair loss, four had patch atrophy, moderate telangiectasia, and/or total hair loss. Conclusions. BCC has a negative effect on patients' quality of life. The study shows that HRQOL normalises shortly after X-ray therapy, despite minor skin manifestations.

摘要

背景。晚期基底细胞癌(BCC)通常采用手术或X线治疗。迄今为止,尚未描述X线治疗对患者健康相关生活质量(HRQOL)的影响。目的。量化X线治疗前后BCC患者的生活质量,并与匹配的健康对照进行比较。材料。25例BCC患者(平均年龄69岁)在X线治疗前、治疗后两周和三个月完成了皮肤病生活质量指数(DLQI),并将其结果与25例匹配对照者的DLQI评分进行比较。结果。与健康对照相比,患者在X线治疗前和治疗后2周的DLQI评分显著更高(P = 0.005;P = 0.000)。从基线到X线治疗后三个月患者DLQI评分显著下降(P = 0.024),此时与健康对照者的评分相似(P = 0.819)。X线治疗后三个月时,8例患者无皮肤反应,11例有轻微萎缩、色素沉着改变和/或轻度脱发;4例有片状萎缩、中度毛细血管扩张和/或全秃。结论BCC对患者生活质量有负面影响;研究表明,尽管有轻微皮肤表现,但X线治疗后不久HRQOL即恢复正常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14be/3539380/1c21ee5b4baf/JSC2012-825095.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14be/3539380/1c21ee5b4baf/JSC2012-825095.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14be/3539380/1c21ee5b4baf/JSC2012-825095.001.jpg

相似文献

1
Skin reactions and quality of life after x-ray therapy of Basal cell carcinoma.基底细胞癌X线治疗后的皮肤反应与生活质量
J Skin Cancer. 2012;2012:825095. doi: 10.1155/2012/825095. Epub 2012 Dec 20.
2
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).维莫德吉停药后的长期疗效以及使用皮肤病生活质量指数(DLQI)评估患者的健康相关生活质量。
Dermatol Ther (Heidelb). 2019 Dec;9(4):719-724. doi: 10.1007/s13555-019-00323-4. Epub 2019 Sep 10.
3
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test.维莫德吉在转移性和晚期基底细胞癌患者中的实际疗效:不良事件特征及使用皮肤病生活质量指数(DLQI)测试评估健康相关生活质量
Dermatol Ther (Heidelb). 2019 Sep;9(3):505-510. doi: 10.1007/s13555-019-0303-4. Epub 2019 Jun 4.
4
Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer.采用皮肤病生活质量指数评估手术治疗对面部非黑素瘤皮肤癌患者生活质量的影响。
Dermatol Ther. 2020 Nov;33(6):e14094. doi: 10.1111/dth.14094. Epub 2020 Aug 14.
5
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).现实生活中使用生物制剂治疗的中度至重度斑块状银屑病患者的患者报告结局与医生报告结局之间的关联(PSO-BIO-REAL)
Dermatol Ther (Heidelb). 2020 Oct;10(5):1099-1109. doi: 10.1007/s13555-020-00428-1. Epub 2020 Aug 6.
6
A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.皮肤科人群中非黑色素瘤皮肤癌患者报告结局测评工具的系统评价
J Am Acad Dermatol. 2013 Aug;69(2):e59-67. doi: 10.1016/j.jaad.2012.09.017. Epub 2012 Oct 24.
7
Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.奥马珠单抗显著改善慢性自发性荨麻疹患者的皮肤科相关生活质量。
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1715-1721. doi: 10.1111/jdv.14384. Epub 2017 Jul 19.
8
Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.乌司奴单抗改善中重度斑块状银屑病患者的健康相关生活质量:来自 PHOENIX 1 试验的结果。
Br J Dermatol. 2010 Jan;162(1):137-46. doi: 10.1111/j.1365-2133.2009.09491.x. Epub 2009 Nov 9.
9
Effects of time and recall of patch test results on quality of life (QoL) after testing. Cross-sectional study analyzing QoL in hand eczema patients 1, 5 and 10 years after patch testing.斑贴试验后时间和对试验结果的回忆对生活质量(QoL)的影响。对 1 、 5 和 10 年后手部湿疹患者进行斑贴试验后 QoL 的横断面研究。
Contact Dermatitis. 2017 Aug;77(2):88-94. doi: 10.1111/cod.12734. Epub 2016 Dec 28.
10
DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.DLQI-R评分提高了皮肤病生活质量指数对银屑病、天疱疮和硬斑病患者的鉴别能力。
Br J Dermatol. 2020 May;182(5):1167-1175. doi: 10.1111/bjd.18435. Epub 2019 Oct 16.

引用本文的文献

1
Quality of Life Before and After Radiation Therapy for Early-Stage Keratinocyte Carcinoma: A Longitudinal Analysis.早期角质细胞癌放射治疗前后的生活质量:纵向分析。
Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1090-1095. doi: 10.1016/j.ijrobp.2023.05.044. Epub 2023 Oct 3.
2
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).维莫德吉停药后的长期疗效以及使用皮肤病生活质量指数(DLQI)评估患者的健康相关生活质量。
Dermatol Ther (Heidelb). 2019 Dec;9(4):719-724. doi: 10.1007/s13555-019-00323-4. Epub 2019 Sep 10.
3

本文引用的文献

1
The role of radiation therapy in the management of skin cancers.放射治疗在皮肤癌治疗中的作用。
Dermatol Clin. 2011 Apr;29(2):287-96, x. doi: 10.1016/j.det.2011.01.004.
2
Quality of life in health care of non-melanoma skin cancer - results of a pilot study.非黑色素瘤皮肤癌的医疗保健中的生活质量-一项试点研究的结果。
J Dtsch Dermatol Ges. 2011 Feb;9(2):129-35. doi: 10.1111/j.1610-0387.2010.07547.x. Epub 2010 Oct 28.
3
Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.
Health-Related Quality of Life, Satisfaction with Care, and Cosmetic Results in Relation to Treatment among Patients with Keratinocyte Cancer in the Head and Neck Area: Results from the PROFILES Registry.
头颈部角化细胞癌患者的健康相关生活质量、护理满意度和美容效果与治疗的关系:来自 PROFILES 注册研究的结果。
Dermatology. 2020;236(2):133-142. doi: 10.1159/000502033. Epub 2019 Aug 21.
4
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test.维莫德吉在转移性和晚期基底细胞癌患者中的实际疗效:不良事件特征及使用皮肤病生活质量指数(DLQI)测试评估健康相关生活质量
Dermatol Ther (Heidelb). 2019 Sep;9(3):505-510. doi: 10.1007/s13555-019-0303-4. Epub 2019 Jun 4.
5
Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids.非黑色素瘤皮肤癌和瘢痕疙瘩的浅表放射治疗应用共识指南。
J Clin Aesthet Dermatol. 2019 Feb;12(2):12-18. Epub 2019 Feb 1.
6
Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma.光动力疗法作为基底细胞癌治疗中一种可能的治疗选择的效用。
Int J Mol Sci. 2015 Sep 28;16(10):23300-17. doi: 10.3390/ijms161023300.
7
Basal cell carcinoma-treatments for the commonest skin cancer.基底细胞癌——最常见皮肤癌的治疗方法。
Dtsch Arztebl Int. 2014 May 30;111(22):389-95. doi: 10.3238/arztebl.2014.0389.
8
Advanced basal cell carcinoma.晚期基底细胞癌
Wien Med Wochenschr. 2013 Aug;163(15-16):347-53. doi: 10.1007/s10354-013-0193-5. Epub 2013 Apr 16.
1978-2007 年丹麦非黑色素瘤皮肤癌发病率趋势:丹麦年轻女性发病率迅速上升。
Int J Cancer. 2010 Nov 1;127(9):2190-8. doi: 10.1002/ijc.25411.
4
Quality of life issues in nonmetastatic skin cancer.非转移性皮肤癌的生活质量问题。
Br J Dermatol. 2010 Jan;162(1):147-51. doi: 10.1111/j.1365-2133.2009.09469.x. Epub 2009 Aug 20.
5
Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments.基于办公室的皮肤癌放射治疗:710例治疗的评估
Int J Dermatol. 2007 May;46(5):453-9. doi: 10.1111/j.1365-4632.2006.03108.x.
6
The skin cancer index: clinical responsiveness and predictors of quality of life.皮肤癌指数:临床反应性及生活质量的预测因素
Laryngoscope. 2007 Mar;117(3):399-405. doi: 10.1097/MLG.0b013e31802e2d88.
7
Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer.非黑色素瘤皮肤癌患者生活质量评估工具的验证
Arch Facial Plast Surg. 2006 Sep-Oct;8(5):314-8. doi: 10.1001/archfaci.8.5.314.
8
Development of the facial skin care index: a health-related outcomes index for skin cancer patients.面部皮肤护理指数的制定:一项针对皮肤癌患者的健康相关结局指数。
Dermatol Surg. 2006 Jul;32(7):924-34; discussion 934. doi: 10.1111/j.1524-4725.2006.32197.x.
9
An assessment of the quality of life in older patients with skin disease.老年皮肤病患者生活质量评估
Br J Dermatol. 2006 Jan;154(1):150-3. doi: 10.1111/j.1365-2133.2005.06959.x.
10
Translating the science of quality of life into practice: What do dermatology life quality index scores mean?将生活质量科学转化为实践:皮肤病生活质量指数评分意味着什么?
J Invest Dermatol. 2005 Oct;125(4):659-64. doi: 10.1111/j.0022-202X.2005.23621.x.